Providence Therapeutics is a biotechnology company that develops a personalized mRNA cancer vaccine designed to treat ovarian cancer.
Providence Therapeutics has raised $2.1M in total funding. The most recent round was Grant. The last funding was announced in December 2021.
Providence Therapeutics's investors include Bill & Melinda Gates Foundation.
Providence Therapeutics is headquartered in Toronto, Canada.
Providence Therapeutics is a biotechnology company that develops a personalized mRNA cancer vaccine designed to treat ovarian cancer.
Providence Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Providence Therapeutics — Funding & Investors." VCBacked, December 7, 2021, https://www.vcbacked.co/company/providence-therapeutics. Accessed September 30, 2026.
VCBacked. (2021). Providence Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/providence-therapeutics
{{cite web |title=Providence Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/providence-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated